Harnessing QSAR and machine learning for the design of hepatocellular carcinoma inhibitors; experimental validation of the cytotoxicity of new compounds against HepG2 cells

Harnessing QSAR and machine learning for the design of hepatocellular carcinoma inhibitors; experimental validation of the cytotoxicity of new compounds against HepG2 cells

Ali S, Putra ID, Aremu AJ, Jit-aree P, Limpachayaporn P, Boonsombat J, Ruchirawat S, Wolschann P, Maitarad P*, Rungrotmongkol T*

Med Drug Discov. 2026;31:100260.